A case of nephrotic syndrome 11 yr post‐kidney transplantation
Shinichi Nishi(Renal Association), Fumitake Gejyo(Niigata University of Pharmacy and Medical and Life Sciences), Bassam Alchi, Kazuhiro Takahashi, Naofumi Imai(Center for Rheumatology), Gen Nakamura(Center for Rheumatology), M Ueno(Center for Rheumatology), Kazuko Kawamura(Niigata University), Sawako Goto, Yoko Kaneko(Keio University), K. Saito(Niigata University)
Cited by 1
Related Papers
NAK is an IκB kinase-activating kinase
|Nature|2000|374
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
|The Lancet|2023|264
Overview of Regular Dialysis Treatment in Japan (as of 31 December 2008)
|Therapeutic Apheresis and Dialysis|2010|228
Successful Efavirenz Dose Reduction in HIV Type 1-Infected Individuals with Cytochrome P450 2B6 *6 and *26
|Clinical Infectious Diseases|2007|222
Inhibition of NFκB Increases the Efficacy of Cisplatin in in Vitro and in Vivo Ovarian Cancer Models
|Journal of Biological Chemistry|2004|212